A Role of Dystroglycan in Schwannoma Cell Adhesion to Laminin*
- Kiichiro Matsumuraद,
- Atsuro Chiba‡‖,
- Hiroki Yamada¶,
- Hiroko Fukuta-Ohi¶,
- Sachiko Fujita¶,
- Tamao Endo‖,
- Akira Kobata‖,
- Louise V. B. Anderson**,
- Ichiro Kanazawa‡,
- Kevin P. Campbell§§¶¶ and
- Teruo Shimizu¶
- From the ¶Department of Neurology and Neuroscience, Teikyo University School of Medicine, Tokyo 173, Japan, ‖Department of Glycobiology, Tokyo Metropolitan Institute of Gerontology, Tokyo 173, Japan, the **University School of Neuroscience and Muscular Dystrophy Group Laboratories, Regional Neuroscience Centre, Newcastle General Hospital, Newcastle-upon-Tyne NE4 6BE, United Kingdom, the‡Department of Neurology, Institute of Brain Research, University of Tokyo Faculty of Medicine, Tokyo 113, Japan, and the¶¶Howard Hughes Medical Institute and Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, Iowa 52242
Abstract
Dystroglycan is encoded by a single gene and cleaved into two proteins α- and β-dystroglycan by posttranslational processing. Recently, α-dystroglycan was demonstrated to be an extracellular laminin-binding protein anchored to the cell membrane by a transmembrane protein β-dystroglycan in striated muscle and Schwann cells. However, the biological functions of the dystroglycan-laminin interaction remain obscure, and in particular, it is still unclear if dystroglycan plays a role in cell adhesion. In the present study, we characterized the role of dystroglycan in the adhesion of schwannoma cells to laminin-1. Immunochemical analysis demonstrated that the dystroglycan complex, comprised of α- and β-dystroglycan, was a major laminin-binding protein complex in the surface membrane of rat schwannoma cell line RT4. It also demonstrated the presence of α-dystroglycan, but not β-dystroglycan, in the culture medium, suggesting secretion of α-dystroglycan by RT4 cells. RT4 cells cultured on dishes coated with laminin-1 became spindle in shape and adhered to the bottom surface tightly. Monoclonal antibody IIH6 against α-dystroglycan was shown previously to inhibit the binding of laminin-1 to α-dystroglycan. In the presence of IIH6, but not several other control antibodies in the culture medium, RT4 cells remained round in shape and did not adhere to the bottom surface. The adhesion of RT4 cells to dishes coated with fibronectin was not affected by IIH6. The known inhibitors of the interaction of α-dystroglycan with laminin-1, including EDTA, sulfatide, fucoidan, dextran sulfate, heparin, and sialic acid, also perturbed the adhesion of RT4 cells to laminin-1, whereas the reagents which do not inhibit the interaction, including dextran, chondroitin sulfate, dermatan sulfate, and GlcNAc, did not. Altogether, these results support a role for dystroglycan as a major cell adhesion molecule in the surface membrane of RT4 cells.
Footnotes
-
↵* This work was supported in part by the Muscular Dystrophy Association of America, grants from the Kato Memorial Bioscience Foundation, the Cell Science Research Foundation, the Science Research Promotion Fund from Japan Private School Promotion Foundation, Research Grant (8A-1 and 8A-2) for Nervous and Mental Disorders from the Ministry of Health and Welfare, and Research Grants (07264239, 06454280, 08457195, 06770463 and 05557037) from the Ministry of Education, Science, Sports and Culture.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵‡ These authors contributed equally to this work.
-
↵§ To whom correspondence should be addressed: Dept. of Neurology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173, Japan. Tel.: 03 3964 1211; Fax: 03 3964 6394; E-mail:k-matsu{at}med.teikyo-u.ac.jp.
-
↵§§ An Investigator of the Howard Hughes Medical Institute.
-
↵1 The abbreviations used are: ECM, extracellular matrix; BSA, bovine serum albumin; cLSM, confocal laser scanning microscope; WGA, wheat germ agglutinin; PBS, phosphate-buffered saline.
-
- Received September 13, 1996.
- Revision received March 3, 1997.











